TenderlineUK
Procurement Intelligence
Official OCDSSearch

Retender radar: UK public contracts ending soon

Every contract in the catalogue with a published end date in the future, one row per contract (lot). A contract ending is a procurement starting, unless the buyer uses a published extension option, which the row shows. Frameworks and DPS are marked: what ends there is the vehicle, not one supplier’s contract.

Contracts ending in the next 12 months

Page 47 · 50 contracts on this page · more available

SortEnding soonestLargest contract valueLargest annual run-rate
FrameworkClear all

1,000+ contracts

  1. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Crescent Pharma Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  2. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Recordati Pharmaceuticals Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  3. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Brown and Burk UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  4. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Macleods Pharma UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  5. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Waymade PLC

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  6. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Roma Pharmaceuticals Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  7. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Synchrony Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  8. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Necessity Supplies Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  9. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Torrent Pharma UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  10. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Focus Pharmaceuticals Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  11. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Cipla

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  12. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Lucane Pharma

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  13. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Stirling Anglian Pharmaceuticals Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  14. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: RPH Pharmaceuticals AB

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  15. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Beaumont Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  16. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: SVP Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  17. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Otsuka Pharmaceuticals (UK) Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  18. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: LogixX Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  19. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Fresenius Kabi Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  20. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Hikma Pharmaceuticals

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  21. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Merck Sharp & Dohme UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  22. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Piramal Critical Care Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  23. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Zentiva Pharma UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  24. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Pfizer Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  25. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Fontus Health Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  26. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Colonis Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  27. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Galvany Pharma

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  28. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Sandoz

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  29. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Essential Pharma

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  30. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Mercury Pharmaceuticals Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  31. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Ascend Laboratories UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  32. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Aguettant Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  33. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: GLAXOSMITHKLINE UK LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  34. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Celix Pharma Ltd.

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  35. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Neon Healthcare

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  36. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: GENNISIUM PHARMA

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  37. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Baxter Healthcare Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  38. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Lundbeck Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  39. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Macure Pharma Aps

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  40. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Flexipharm Austrading Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  41. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Milpharm Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  42. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Kent Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  43. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: medac Pharma LLP

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  44. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: MSN Laboratories Europe Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  45. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Novumgen Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  46. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Bowmed Ibisqus Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  47. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Aspen Pharmacare UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  48. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Viatris UK Healthcare Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  49. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Teva UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  50. Ends · in 352 daysFramework re-let

    Wave 15b - Hospital Only DCE & DSW regions

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Perennial Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Sept 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
How to read the radar
  • End date is the contract period end the buyer published on the notice. Contracts without an end date are not on the radar.
  • Extension option means the notice publishes a renewal or option clause; the buyer may extend instead of retendering. Hide them to see contracts that must be re-procured.
  • Incumbent is the supplier named on the award behind the contract. A panel (several suppliers on one award) is shown as a panel; no single incumbent is invented.
  • Annual run-rate = published GBP value ÷ published term, only for a single supplier, a term of six months or more and a plain contract (not a framework or DPS ceiling).
  • Counts are exact for the time-horizon and sector filters. With other filters, a result above 1,000 contracts shows as “1,000+”.
  • Source. Official UK procurement notices, reused under the Open Government Licence v3.0; the radar is rebuilt nightly. How we count: methodology.